Herlyn M - Search Results

1

PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas.

Lee JT, Li L, Brafford PA, van den Eijnden M, Halloran MB, Sproesser K, Haass NK, Smalley KS, Tsai J, Bollag G, Herlyn M. Lee JT, et al. Among authors: herlyn m. Pigment Cell Melanoma Res. 2010 Dec;23(6):820-7. doi: 10.1111/j.1755-148X.2010.00763.x. Pigment Cell Melanoma Res. 2010. PMID: 20973932 Free PMC article.

2

Cellular pathways leading to melanoma differentiation: therapeutic implications.

Soballe PW, Herlyn M. Soballe PW, et al. Among authors: herlyn m. Melanoma Res. 1994 Aug;4(4):213-23. doi: 10.1097/00008390-199408000-00003. Melanoma Res. 1994. PMID: 7950357 Review.

3

Interactions of melanocytes and melanoma cells with the microenvironment.

Herlyn M, Shih IM. Herlyn M, et al. Pigment Cell Res. 1994 Apr;7(2):81-8. doi: 10.1111/j.1600-0749.1994.tb00025.x. Pigment Cell Res. 1994. PMID: 8066024 Review.

4

An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin.

Satyamoorthy K, Oka M, Herlyn M. Satyamoorthy K, et al. Among authors: herlyn m. Pigment Cell Res. 2000;13 Suppl 8:87-93. doi: 10.1034/j.1600-0749.13.s8.16.x. Pigment Cell Res. 2000. PMID: 11041363

5

Emerging concepts and technologies in melanoma research.

Herlyn M. Herlyn M. Melanoma Res. 2002 Feb;12(1):3-8. doi: 10.1097/00008390-200202000-00002. Melanoma Res. 2002. PMID: 11828252 Review.

6

The great escape: another way for melanoma to leave physiological control?

Smalley KS, Herlyn M. Smalley KS, et al. Among authors: herlyn m. J Invest Dermatol. 2003 Oct;121(4):xi-xii. doi: 10.1046/j.1523-1747.2003.12506.x. J Invest Dermatol. 2003. PMID: 14632176 Free article. Review. No abstract available.

7

The role of altered cell-cell communication in melanoma progression.

Haass NK, Smalley KS, Herlyn M. Haass NK, et al. Among authors: herlyn m. J Mol Histol. 2004 Mar;35(3):309-18. doi: 10.1023/b:hijo.0000032362.35354.bb. J Mol Histol. 2004. PMID: 15339050 Review.

8

Loitering with intent: new evidence for the role of BRAF mutations in the proliferation of melanocytic lesions.

Smalley KS, Herlyn M. Smalley KS, et al. Among authors: herlyn m. J Invest Dermatol. 2004 Oct;123(4):xvi-xvii. doi: 10.1111/j.0022-202X.2004.23430.x. J Invest Dermatol. 2004. PMID: 15373800 Free article. Review. No abstract available.

9

Cultivation of normal human epidermal melanocytes in the absence of phorbol esters.

Hsu MY, Li L, Herlyn M. Hsu MY, et al. Among authors: herlyn m. Methods Mol Med. 2005;107:13-28. doi: 10.1385/1-59259-861-7:013. Methods Mol Med. 2005. PMID: 15492362 No abstract available.

10

Gene expression profiling of melanoma cells - searching the haystack.

Brafford P, Herlyn M. Brafford P, et al. Among authors: herlyn m. J Transl Med. 2005 Jan 13;3(1):2. doi: 10.1186/1479-5876-3-2. J Transl Med. 2005. PMID: 15649323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

682 results

Search Page

Filters